Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality: A pilot study

Bethlehem Mengesha; Alex Blatt; Olga Bloch; Micha J. Rapoport

doi:10.1111/eci.13897

Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality: A pilot study

Bethlehem Mengesha^*, Alex Blatt, Olga Bloch, Micha J. Rapoport

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Comment/debate

Original language	English
Journal	European Journal of Clinical Investigation
DOIs	https://doi.org/10.1111/eci.13897
State	Accepted/In press - 2022

Keywords

cardiovascular outcome
DPP4
GLP-1
myocardial infarction

Access to Document

10.1111/eci.13897

Cite this

Mengesha, B., Blatt, A., Bloch, O., & Rapoport, M. J. (Accepted/In press). Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality: A pilot study. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.13897

@article{d2f4b75c02de4acf9db5b470d3e3bc54,

title = "Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality: A pilot study",

keywords = "cardiovascular outcome, DPP4, GLP-1, myocardial infarction",

author = "Bethlehem Mengesha and Alex Blatt and Olga Bloch and Rapoport, {Micha J.}",

year = "2022",

doi = "10.1111/eci.13897",

language = "אנגלית",

journal = "European Journal of Clinical Investigation",

issn = "0014-2972",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality : A pilot study. / Mengesha, Bethlehem; Blatt, Alex; Bloch, Olga et al.

In: European Journal of Clinical Investigation, 2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality

T2 - A pilot study

AU - Mengesha, Bethlehem

AU - Blatt, Alex

AU - Bloch, Olga

AU - Rapoport, Micha J.

PY - 2022

Y1 - 2022

KW - cardiovascular outcome

KW - DPP4

KW - GLP-1

KW - myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=85142864167&partnerID=8YFLogxK

U2 - 10.1111/eci.13897

DO - 10.1111/eci.13897

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 36345656

AN - SCOPUS:85142864167

SN - 0014-2972

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

ER -

Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality: A pilot study

Keywords

Access to Document

Other files and links

Cite this